We are evaluating a new treatment for patients with pancreatic, lung, breast, and colorectal cancers. The study aims to assess its safety and how well it works in these cancer types.
Health conditions and diseases that the clinical trial is designed to study and treat.
Non-Small Cell Lung Cancer (NSCLC) is a type of lung cancer that is not small cell carcinoma, making up about 85% of lung cancer cases. It can be locally advanced or metastatic, meaning it may not be removable by surgery and can spread to other parts of the body.
Pancreatic Ductal Adenocarcinoma (PDAC) is a common type of pancreatic cancer that often goes undetected until advanced stages. It is locally advanced or metastatic, meaning it cannot be surgically removed and may have spread.
Colorectal Cancer (CRC) refers to cancer that starts in the colon or rectum. It can be locally advanced or metastatic, indicating it has spread beyond the original site.
Breast Cancer is a type of cancer that forms in the cells of the breasts. It can be locally advanced or metastatic, meaning it may have spread to other parts of the body.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
